Ballentine Partners’s Ambev ABEV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEV
SCP
NAMI
BIP
ETC
Ballentine Partners's ABEV Position: Q2 2026 in Review
Ballentine Partners reduced its Ambev (ABEV) stake by 22% in Q2 2026, selling an estimated $58K and leaving 63,955 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #1011.
Ballentine Partners first reported a position in ABEV in Q1 2022 and has held it in 17 quarters since. The position peaked at $241K in Q1 2026. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.
- Ballentine Partners held 63,955 shares of Ambev worth $201K as of Q2 2026.
- Ballentine Partners sold 18,550 Ambev shares in Q2 2026, an estimated $58K.
- Ambev made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #1011 holding.
- Ballentine Partners first reported a position in Ambev in Q1 2022 and has held it in 17 quarters since.
- Ballentine Partners's Ambev position peaked at $241K in Q1 2026.
- 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.
Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.